Types of combined oral contraceptives used by US womenSTIDHAM HALL, Kelli; TRUSSELL, James.Contraception (Stoneham). 2012, Vol 86, Num 6, pp 659-665, issn 0010-7824, 7 p.Article

Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese womenWEI, W; LI, Y; CHEN, F et al.Journal of human hypertension. 2011, Vol 25, Num 6, pp 364-371, issn 0950-9240, 8 p.Article

Sex hormone-binding globulin: A surrogate marker for the prothrombotic effects of combined oral contraceptivesVAN ROOIJEN, M; SILVEIRA, A; HAMSTEN, A et al.American journal of obstetrics and gynecology. 2004, Vol 190, Num 2, pp 332-337, issn 0002-9378, 6 p.Article

Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparationsSTANCZYK, Frank Z; ARCHER, David F.Contraception (Stoneham). 2014, Vol 89, Num 4, pp 242-252, issn 0010-7824, 11 p.Article

Oral contraception in Denmark 1998-2010WILSON, Nadia M; LAURSEN, Maja; LIDEGAARD, Øjvind et al.Acta obstetricia et gynecologica scandinavica. 2012, Vol 91, Num 7, pp 810-815, issn 0001-6349, 6 p.Article

The evolution of combined oral contraception: improving the risk-to-benefit ratioBURKMAN, Ronald; BELL, Carrie; SERFATY, David et al.Contraception (Stoneham). 2011, Vol 84, Num 1, pp 19-34, issn 0010-7824, 16 p.Article

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in PolandGOLBS, S; DOMHARDT, R; RADOWICKY, S et al.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, Num 9, pp 585-592, issn 0379-0355, 8 p.Article

Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized studyNAPPI, C; DI SPIEZIO SARDO, A; ACUNZO, G et al.Contraception (Stoneham). 2003, Vol 67, Num 5, pp 355-359, issn 0010-7824, 5 p.Article

Pharmacokinetics of a combined oral contraceptive in obese and normal-weight womenWESTHOFF, Carolyn L; TORGAL, Anupama H; MAYEDA, Elizabeth R et al.Contraception (Stoneham). 2010, Vol 81, Num 6, pp 474-480, issn 0010-7824, 7 p.Article

Estradiol Valerate/Dienogest: A Novel Combined Oral ContraceptiveBORGELT, Laura M; MARTELL, Chad W.Clinical therapeutics. 2012, Vol 34, Num 1, pp 37-55, issn 0149-2918, 19 p.Article

Hormonal Contraceptive Continuation and Switching in South Africa: Implications for Evaluating the Association of Injectable Hormonal Contraceptive Use and HIVSMIT, Jennifer A; BEKSINSKA, Mags E.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 3, pp 363-365, issn 1525-4135, 3 p.Article

Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 yearSTEPHENSON, Judith; SHAWE, Jill; PANICKER, Sabeena et al.Contraception (Stoneham). 2013, Vol 88, Num 4, pp 523-531, issn 0010-7824, 9 p.Article

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenKLIPPING, Christine; DUIJKERS, Ingrid; TRUMMER, Dietmar et al.Contraception (Stoneham). 2008, Vol 78, Num 1, pp 16-25, issn 0010-7824, 10 p.Article

Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraceptionBEKSINSKA, Mags E; KLEINSCHMIDT, Immo; SMIT, Jenni A et al.Contraception (Stoneham). 2007, Vol 75, Num 6, pp 438-443, issn 0010-7824, 6 p.Article

Steroid receptor expression in the vulvar vestibular mucosa : effects of oral contraceptives and menstrual cycleJOHANNESSON, Ulrika; SAHLIN, Lena; MASIRONI, Britt et al.Contraception (Stoneham). 2007, Vol 76, Num 4, pp 319-325, issn 0010-7824, 7 p.Article

Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)DE VISSE, S. J; UCHIDA, N; VAN VLIET-DASKALOPOULOU, E et al.Contraception (Stoneham). 2003, Vol 68, Num 3, pp 195-202, issn 0010-7824, 8 p.Article

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenoneBACHMANN, Gloria; SULAK, Patricia J; SAMPSON-LANDERS, Carole et al.Contraception (Stoneham). 2004, Vol 70, Num 3, pp 191-198, issn 0010-7824, 8 p.Article

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech republicGOLBS, S; DOMHARDT, R; PRESL, J et al.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, Num 10, pp 689-696, issn 0379-0355, 8 p.Article

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trialHOVANESSIAN-LARSEN, Linda; TAYLOR, Deshawn; HAWES, Debra et al.Contraception (Stoneham). 2012, Vol 86, Num 3, pp 238-243, issn 0010-7824, 6 p.Article

Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic diseaseGAFFIELD, Mary E; KAPP, Nathalie; CURTIS, Kathryn M et al.Contraception (Stoneham). 2009, Vol 80, Num 4, pp 363-371, issn 0010-7824, 9 p.Article

Opinion and experience of Brazilian women regarding menstrual bleeding and use of combined oral contraceptivesMAKUCH, Maria Y; DUARTE-OSIS, Maria J; DE PADUA, Karla S et al.International journal of gynaecology and obstetrics. 2012, Vol 117, Num 1, pp 5-9, issn 0020-7292, 5 p.Article

Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimenHEMADI, Laszló; MARR, Joachim; TRUMMER, Dietmar et al.Contraception (Stoneham). 2009, Vol 80, Num 1, pp 18-24, issn 0010-7824, 7 p.Article

Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controlsBORGSTRÖM, Anna; KASK, Kristiina; GULINELLO, Maria et al.Psychoneuroendocrinology. 2008, Vol 33, Num 4, pp 487-496, issn 0306-4530, 10 p.Article

Efavirenz, in Contrast to Nevirapine, is Associated With Unfavorable Progesterone and Antiretroviral Levels When Coadministered With Combined Oral ContraceptivesKANCHEVA LANDOLT, Nadia; PHANUPHAK, Nittaya; LANGE, Joep M. A et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 5, pp 534-539, issn 1525-4135, 6 p.Article

Should we do more to improve oral contraceptive continuation?CASTANO, Paula M; O'CONNELL WHITE, Katharine.Women's health (London. Print). 2013, Vol 9, Num 2, pp 145-156, issn 1745-5057, 12 p.Article